The purpose of this study is to validate TNM-Immunoscore in resected non-small cell lung cancer.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* resectable NSCLC
* Age 18 and above
* no other malignancy last 5 years
* informed consent
Exclusion Criteria:
* multiple tumor foci
* preoperative chemo- or radiotherapy
* non-NSCLC histology
* no tissue available for study
* metastasis
Primary outcome measure(s)
Overall survival — 5 year follow-up Overall survival in the 1) overall population and in the 2) squamous cell carcinoma and 3) adenocarcinoma subgroups.
Trial sites (5)
Facility
City
Region
Status
Rigshospitalet
Copenhagen
København Ø
Odense Universitetshospital
Odense
Denmark
Oslo University Hospital
Oslo
Norway
University Hospital of North Norway
Tromsø
Norway
St.Olav Hospital, University Hospital of Trondheim
Trondheim
Norway
More University Hospital of North Norway trials in Denmark
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.